140 related articles for article (PubMed ID: 22965877)
41. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
[TBL] [Abstract][Full Text] [Related]
42. Activation of glycogen synthase kinase 3beta promotes the intermolecular association of tau. The use of fluorescence resonance energy transfer microscopy.
Chun W; Johnson GV
J Biol Chem; 2007 Aug; 282(32):23410-7. PubMed ID: 17565981
[TBL] [Abstract][Full Text] [Related]
43. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
44. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
[TBL] [Abstract][Full Text] [Related]
45. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro.
Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q
J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328
[TBL] [Abstract][Full Text] [Related]
46. Interactions between glycogen synthase kinase 3beta, protein kinase B, and protein phosphatase 2A in tau phosphorylation in mouse N2a neuroblastoma cells.
Zhou XW; Winblad B; Guan Z; Pei JJ
J Alzheimers Dis; 2009; 17(4):929-37. PubMed ID: 19542610
[TBL] [Abstract][Full Text] [Related]
47. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
48. Effects of progesterone and its reduced metabolites, dihydroprogesterone and tetrahydroprogesterone, on the expression and phosphorylation of glycogen synthase kinase-3 and the microtubule-associated protein tau in the rat cerebellum.
Guerra-Araiza C; Amorim MA; Camacho-Arroyo I; Garcia-Segura LM
Dev Neurobiol; 2007 Mar; 67(4):510-20. PubMed ID: 17443805
[TBL] [Abstract][Full Text] [Related]
49. The Interplay between GSK3β and Tau Ser262 Phosphorylation during the Progression of Tau Pathology.
Song L; Oseid DE; Wells EA; Robinson AS
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232909
[TBL] [Abstract][Full Text] [Related]
50. Effect of chronic administration of estradiol, progesterone, and tibolone on the expression and phosphorylation of glycogen synthase kinase-3β and the microtubule-associated protein tau in the hippocampus and cerebellum of female rat.
Pinto-Almazán R; Calzada-Mendoza CC; Campos-Lara MG; Guerra-Araiza C
J Neurosci Res; 2012 Apr; 90(4):878-86. PubMed ID: 22183707
[TBL] [Abstract][Full Text] [Related]
51. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
[TBL] [Abstract][Full Text] [Related]
52. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.
Flaherty DB; Soria JP; Tomasiewicz HG; Wood JG
J Neurosci Res; 2000 Nov; 62(3):463-72. PubMed ID: 11054815
[TBL] [Abstract][Full Text] [Related]
53. New methods based on capillary electrophoresis for in vitro evaluation of protein tau phosphorylation by glycogen synthase kinase 3-β.
Nehmé H; Chantepie S; Defert J; Morin P; Papy-Garcia D; Nehmé R
Anal Bioanal Chem; 2015 Apr; 407(10):2821-8. PubMed ID: 25711986
[TBL] [Abstract][Full Text] [Related]
54. Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport.
Tatebayashi Y; Haque N; Tung YC; Iqbal K; Grundke-Iqbal I
J Cell Sci; 2004 Apr; 117(Pt 9):1653-63. PubMed ID: 15075227
[TBL] [Abstract][Full Text] [Related]
55. Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cells.
Yoon SY; Park JS; Choi JE; Choi JM; Lee WJ; Kim SW; Kim DH
Neurobiol Dis; 2010 Nov; 40(2):449-55. PubMed ID: 20655383
[TBL] [Abstract][Full Text] [Related]
56. Tau overexpression in transgenic mice induces glycogen synthase kinase 3beta and beta-catenin phosphorylation.
Shim SB; Lim HJ; Chae KR; Kim CK; Hwang DY; Jee SW; Lee SH; Sin JS; Leem YH; Lee SH; Cho JS; Lee HH; Choi SY; Kim YK
Neuroscience; 2007 May; 146(2):730-40. PubMed ID: 17337327
[TBL] [Abstract][Full Text] [Related]
57. Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation.
Avraham E; Szargel R; Eyal A; Rott R; Engelender S
J Biol Chem; 2005 Dec; 280(52):42877-86. PubMed ID: 16174773
[TBL] [Abstract][Full Text] [Related]
58. GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions.
Zhu H; Zhang W; Zhao Y; Shu X; Wang W; Wang D; Yang Y; He Z; Wang X; Ying Y
Mol Neurodegener; 2018 Nov; 13(1):62. PubMed ID: 30466464
[TBL] [Abstract][Full Text] [Related]
59. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
[TBL] [Abstract][Full Text] [Related]
60. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
